复发性-话题@MedSci

#复发性#

452篇内容 | 2982人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1909888, encodeId=968a19098885c, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=FDA批准针对复发性心包炎的疗法, objectType=article, longId=209540, objectId=5394209540b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5394209540b9, replyNumber=0, likeNumber=80, createdTime=2021-12-09, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5394209540b9, moduleTitle=FDA批准针对复发性心包炎的疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5394209540b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909836, encodeId=66c11909836de, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：Avelumab治疗复发性/难治性结外NK/T细胞淋巴瘤, objectType=article, longId=199475, objectId=ce771994e50b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce771994e50b, replyNumber=0, likeNumber=91, createdTime=2021-05-02, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce771994e50b, moduleTitle=Blood：Avelumab治疗复发性/难治性结外NK/T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce771994e50b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909849, encodeId=a9ab190984934, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JNNP:扩展MOG抗体相关疾病（MOGAD）的表型：半个世纪的癫痫和复发性视神经炎, objectType=article, longId=203645, objectId=43c720364596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43c720364596, replyNumber=0, likeNumber=97, createdTime=2021-06-30, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43c720364596, moduleTitle=JNNP:扩展MOG抗体相关疾病（MOGAD）的表型：半个世纪的癫痫和复发性视神经炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43c720364596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909908, encodeId=ffdb190990829, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Nat Med：局部输注HER2特异性CAR-T细胞治疗复发性/难治性中枢神经系统肿瘤儿童和年轻患者的临床研究, objectType=article, longId=214242, objectId=a2d6214242c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2d6214242c7, replyNumber=0, likeNumber=22, createdTime=2022-03-17, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2d6214242c7, moduleTitle=Nat Med：局部输注HER2特异性CAR-T细胞治疗复发性/难治性中枢神经系统肿瘤儿童和年轻患者的临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2d6214242c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909870, encodeId=21b119098e043, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JCO || 复发性或持续性卵巢癌：纳武利尤单抗联合伊匹单抗的缓解率高, objectType=article, longId=206079, objectId=feef2060e9a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=feef2060e9a2, replyNumber=0, likeNumber=105, createdTime=2021-02-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=feef2060e9a2, moduleTitle=JCO || 复发性或持续性卵巢癌：纳武利尤单抗联合伊匹单抗的缓解率高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feef2060e9a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909886, encodeId=61c3190988642, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Eur Radiol：复发性甲状腺癌一旦侵犯了气管，射频消融治疗效果如何？, objectType=article, longId=208462, objectId=a26320846274, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a26320846274, replyNumber=0, likeNumber=45, createdTime=2022-01-03, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a26320846274, moduleTitle=Eur Radiol：复发性甲状腺癌一旦侵犯了气管，射频消融治疗效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a26320846274)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909843, encodeId=3f11190984347, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=CSCO 2020丨马宽生教授：射频消融联合PD-1单抗治疗复发性小肝癌的疗效分析, objectType=article, longId=201341, objectId=184820134173, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=184820134173, replyNumber=0, likeNumber=34, createdTime=2021-02-19, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=184820134173, moduleTitle=CSCO 2020丨马宽生教授：射频消融联合PD-1单抗治疗复发性小肝癌的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=184820134173)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909893, encodeId=d8871909893b9, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=NEJM：3岁以下儿童复发性急性中耳炎的治疗选择——鼓室造口管植入vs抗菌治疗, objectType=article, longId=211278, objectId=be932112e871, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be932112e871, replyNumber=0, likeNumber=68, createdTime=2021-10-19, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be932112e871, moduleTitle=NEJM：3岁以下儿童复发性急性中耳炎的治疗选择——鼓室造口管植入vs抗菌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be932112e871)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909862, encodeId=1fe019098624d, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=J Immunother Cancer：度伐单抗+曲美单抗±立体定向体部放疗治疗复发性小细胞肺癌的疗效和安全性, objectType=article, longId=205702, objectId=9b3d205e0248, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b3d205e0248, replyNumber=0, likeNumber=65, createdTime=2021-09-07, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b3d205e0248, moduleTitle=J Immunother Cancer：度伐单抗+曲美单抗±立体定向体部放疗治疗复发性小细胞肺癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b3d205e0248)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909905, encodeId=f4451909905b8, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Nat Commun：Notch信号通路影响复发性小细胞肺癌患者对免疫检查点阻断治疗的疗效, objectType=article, longId=213470, objectId=1c222134e0e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c222134e0e8, replyNumber=0, likeNumber=74, createdTime=2021-12-18, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c222134e0e8, moduleTitle=Nat Commun：Notch信号通路影响复发性小细胞肺癌患者对免疫检查点阻断治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c222134e0e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909884, encodeId=800e190988494, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=J Clin Oncol：PI3Kδ/CK1ε双重抑制剂Umbralisib用于治疗复发性/难治性惰性淋巴瘤, objectType=article, longId=208223, objectId=84b3208223f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84b3208223f8, replyNumber=0, likeNumber=94, createdTime=2021-10-04, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84b3208223f8, moduleTitle=J Clin Oncol：PI3Kδ/CK1ε双重抑制剂Umbralisib用于治疗复发性/难治性惰性淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84b3208223f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909838, encodeId=8d1c1909838a6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JAMA Neurol：复发性暂时性整体遗忘症风险因素研究, objectType=article, longId=200130, objectId=7f152001309b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f152001309b, replyNumber=0, likeNumber=56, createdTime=2021-04-08, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f152001309b, moduleTitle=JAMA Neurol：复发性暂时性整体遗忘症风险因素研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f152001309b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909859, encodeId=9b09190985923, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet Neurology：托珠单抗与硫唑嘌呤治疗高度复发性视神经脊髓炎频谱障碍（TANGO）的安全性和有效性：一项开放性、多中心、随机、2期试验, objectType=article, longId=204850, objectId=6b38204850bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b38204850bb, replyNumber=0, likeNumber=78, createdTime=2021-03-25, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b38204850bb, moduleTitle=Lancet Neurology：托珠单抗与硫唑嘌呤治疗高度复发性视神经脊髓炎频谱障碍（TANGO）的安全性和有效性：一项开放性、多中心、随机、2期试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b38204850bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909877, encodeId=0f5219098e71a, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=BJU Int：系统靶向治疗复发性肾细胞癌中的辅助舒尼替尼治疗结果 , objectType=article, longId=207565, objectId=662820e56572, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=662820e56572, replyNumber=0, likeNumber=91, createdTime=2021-05-23, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=662820e56572, moduleTitle=BJU Int：系统靶向治疗复发性肾细胞癌中的辅助舒尼替尼治疗结果 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=662820e56572)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909895, encodeId=3e771909895fd, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet oncol：派姆单抗联合西妥昔单抗治疗复发性/转移性HNSCC的疗效和安全性, objectType=article, longId=211288, objectId=122f21128838, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=122f21128838, replyNumber=0, likeNumber=62, createdTime=2021-12-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=122f21128838, moduleTitle=Lancet oncol：派姆单抗联合西妥昔单抗治疗复发性/转移性HNSCC的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=122f21128838)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909852, encodeId=2e0319098529c, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=复发性AML治疗的突破：GoldenBiotech报告了Antroquinonol的试验进展, objectType=article, longId=203852, objectId=f15b203852d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f15b203852d0, replyNumber=0, likeNumber=77, createdTime=2021-10-31, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f15b203852d0, moduleTitle=复发性AML治疗的突破：GoldenBiotech报告了Antroquinonol的试验进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f15b203852d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909831, encodeId=844f190983126, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=微生物组疗法治疗癌症！复发性胶质母细胞瘤的治疗或迎来新希望, objectType=article, longId=198451, objectId=611b1984514b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=611b1984514b, replyNumber=0, likeNumber=74, createdTime=2021-04-11, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=611b1984514b, moduleTitle=微生物组疗法治疗癌症！复发性胶质母细胞瘤的治疗或迎来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=611b1984514b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909885, encodeId=2db91909885fd, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet oncol：二次减瘤术对于铂敏感的复发性卵巢癌到底有无益处？, objectType=article, longId=208242, objectId=c6c320824279, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6c320824279, replyNumber=0, likeNumber=99, createdTime=2022-01-03, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6c320824279, moduleTitle=Lancet oncol：二次减瘤术对于铂敏感的复发性卵巢癌到底有无益处？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6c320824279)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909830, encodeId=96221909830d6, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Neurology：早期复发性TIA的特征、频率和结局, objectType=article, longId=198426, objectId=e942198426ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e942198426ef, replyNumber=0, likeNumber=77, createdTime=2021-06-22, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e942198426ef, moduleTitle=Neurology：早期复发性TIA的特征、频率和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e942198426ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909876, encodeId=6e0919098e647, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet Haematol：依鲁替尼加用Ublituximab可显著提高复发性/难治性慢性淋巴细胞白血病患者的缓解率, objectType=article, longId=207517, objectId=3e5020e5170d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e5020e5170d, replyNumber=0, likeNumber=71, createdTime=2021-03-25, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e5020e5170d, moduleTitle=Lancet Haematol：依鲁替尼加用Ublituximab可显著提高复发性/难治性慢性淋巴细胞白血病患者的缓解率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e5020e5170d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

复发性

2020-05-29

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

FDA批准针对复发性心包炎的疗法

2021-12-09

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：Avelumab治疗复发性/难治性结外NK/T细胞淋巴瘤

2021-05-02

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JNNP:扩展MOG抗体相关疾病（MOGAD）的表型：半个世纪的癫痫和复发性视神经炎

2021-06-30

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Nat Med：局部输注HER2特异性CAR-T细胞治疗复发性/难治性中枢神经系统肿瘤儿童和年轻患者的临床研究

2022-03-17

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JCO || 复发性或持续性卵巢癌：纳武利尤单抗联合伊匹单抗的缓解率高

2021-02-12

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Eur Radiol：复发性甲状腺癌一旦侵犯了气管，射频消融治疗效果如何？

2022-01-03

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

CSCO 2020丨马宽生教授：射频消融联合PD-1单抗治疗复发性小肝癌的疗效分析

2021-02-19

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

NEJM：3岁以下儿童复发性急性中耳炎的治疗选择——鼓室造口管植入vs抗菌治疗

2021-10-19

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

J Immunother Cancer：度伐单抗+曲美单抗±立体定向体部放疗治疗复发性小细胞肺癌的疗效和安全性

2021-09-07

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Nat Commun：Notch信号通路影响复发性小细胞肺癌患者对免疫检查点阻断治疗的疗效

2021-12-18

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

J Clin Oncol：PI3Kδ/CK1ε双重抑制剂Umbralisib用于治疗复发性/难治性惰性淋巴瘤

2021-10-04

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JAMA Neurol：复发性暂时性整体遗忘症风险因素研究

2021-04-08

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet Neurology：托珠单抗与硫唑嘌呤治疗高度复发性视神经脊髓炎频谱障碍（TANGO）的安全性和有效性：一项开放性、多中心、随机、2期试验

2021-03-25

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

BJU Int：系统靶向治疗复发性肾细胞癌中的辅助舒尼替尼治疗结果

2021-05-23

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet oncol：派姆单抗联合西妥昔单抗治疗复发性/转移性HNSCC的疗效和安全性

2021-12-26

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

复发性AML治疗的突破：GoldenBiotech报告了Antroquinonol的试验进展

2021-10-31

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

微生物组疗法治疗癌症！复发性胶质母细胞瘤的治疗或迎来新希望

2021-04-11

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet oncol：二次减瘤术对于铂敏感的复发性卵巢癌到底有无益处？

2022-01-03

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Neurology：早期复发性TIA的特征、频率和结局

2021-06-22

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet Haematol：依鲁替尼加用Ublituximab可显著提高复发性/难治性慢性淋巴细胞白血病患者的缓解率

2021-03-25

科室
- - 订阅+
  - 更多科室
工具
服务